E. Coli Is Eating Away At Chipotle Sales

Chipotle E Coli Breakout

The E. Coli outbreak at Chipotle is crashing sales and the company’s shares are following along.

Shares at Chipotle are down 7% in after-hours trading after the company announced 4th quarter sales are expected to fall by 8%.

The company noted in an SEC filing that sales have fluctuated a great deal along with developments in the E. coli outbreak — falling when stores closed, but rebounding when they reopen.

“Future sales trends may be significantly influenced by further developments, including potential additional announcements from federal and state health authorities,” Chipotle (CMG) said in the filing.

The CDC has reported more than 50 infections since the start of the E. Coli outbreak. Those affected live in

California, Minnesota, Ohio, New York, Oregon, Illinois, Pennsylvania, Maryland, and Washington.

Because of the outbreak the company is lowering its 2016 sales projection.

In addition, Chipotle said it expects to spend between $6 million and $8 million to replace food, send food samples for analysis, test restaurants and consult with advisers.

The company has not put a price on expected legal costs at this time.

“As a restaurant company, nothing is more important to us than serving our guests food that is delicious and safe to eat,” Chipotle said. “Since this incident began, we have significantly increased our efforts to ensure that our teams are adhering to all of our food safety protocols.”

The company is also spending money to create new procedures to avoid further E. Coli outbreaks.

Written by Peter Mondrose

Peter Mondrose

Peter Mondrose is the Editor-In-Chief at BusinessPundit. He received his degree in Economics in 1998 and a second degree in Journalism in 2004. He has served as a financial adviser, market trader, and freelance journalist for the last 11 years. When he's not investigating market conditions and reporting on workplace news, he can be found traveling with his wife, dog, and laptop. He can be reached at PeterMondrose@BusinessPundit.com or (929) 265-0240.